Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 22, 2014
Previous Article Next Article

Pharmaceutical cocrystals and a nitrate salt of voriconazole

Author affiliations

Abstract

Voriconazole ((2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, VZL) is an antifungal drug with low aqueous solubility of 0.71 mg mL−1 and a BCS class II drug (Biopharmaceutics Classification System) of the azole family. We have prepared a nitrate salt and three cocrystals of VZL with p-hydroxybenzoic acid, p-aminobenzoic acid (both are GRAS compounds) and m-nitrobenzoic acid coformers to improve the physicochemical properties. All four multi-component crystals of voriconazole were obtained by solution crystallization as well as solid-state grinding and their structures were confirmed by X-ray diffraction, FT-IR, Raman and NMR spectroscopy, and thermal techniques. VZL–PHBA and VZL–PABA are isostructural based on XPac calculations and molecular packing arrangement. A notable result from a crystal engineering viewpoint is that the supramolecular synthon between the basic drug and the acidic coformer undergoes a switch based on the pKa of the acid.

Graphical abstract: Pharmaceutical cocrystals and a nitrate salt of voriconazole

Back to tab navigation

Supplementary files

Article information


Submitted
15 Nov 2013
Accepted
16 Dec 2013
First published
16 Dec 2013

CrystEngComm, 2014,16, 4722-4731
Article type
Paper
Author version available

Pharmaceutical cocrystals and a nitrate salt of voriconazole

S. S. Kumar, R. Thakuria and A. Nangia, CrystEngComm, 2014, 16, 4722
DOI: 10.1039/C3CE42324G

Social activity

Search articles by author

Spotlight

Advertisements